The ovine urokinase plasminogen activator and its receptor cDNAs: Molecular cloning, characterization and expression in various tissues

Gene

Volumn 443, Issue 1-2, 2009, Pages 158-169

  Theodorou, Giorgos ^a   Bizelis, Iosif ^a   Rogdakis, Emmanuel ^a   Politis, Ioannis ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

cDNA; Homologue model; Mammary gland; Ovine; u PA; u PAR

Indexed keywords

COMPLEMENTARY DNA; UROKINASE; UROKINASE RECEPTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BASE PAIRING; BREAST; CEREBELLUM; CONTROLLED STUDY; EWE; FEMALE; GENE EXPRESSION REGULATION; HEART; INVOLUTION; KIDNEY; LIVER; MAMMARY GLAND; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FEMALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SHEEP; UNTRANSLATED REGIONS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

OVIS;

EID: 67449099051     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.04.008     Document Type: Article

References (31)

1. Behrendt N., Ploug M., Patthy L., Houen G., Blasi F., and Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem. 266 (1991) 7842-7847
2. Bhuvarahamurthy V., et al. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Oncol. Rep. 14 (2005) 777-782
3. Bulcao C., Ferreira S.R., Giuffrida F.M., and Ribeiro-Filho F.F. The new adipose tissue and adipocytokines. Current Diabetes Reviews 2 (2006) 19-28
4. Busso N., Huarte J., Vassalli J.D., Sappino A.P., and Belin D. Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. J. Biol. Chem. 264 (1989) 7455-7457
5. Dano K., et al. Plasminogen activation and cancer. Thromb. Haemost. 93 (2005) 676-681
6. Estreicher A., Wohlwend A., Belin D., Schleuning W.D., and Vassalli J.D. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264 (1989) 1180-1189
7. Felsenstein J. PHYLIP - Phylogeny Inference Package (Version 3.2). Cladistics 5 (1989) 164-166
8. Fish P.V., et al. Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines. J. Med. Chem. 50 (2007) 2341-2351
9. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
10. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc. Nutr. Soc. 64 (2005) 163-169
11. Huai Q., et al. Structure of human urokinase plasminogen activator in complex with its receptor. Science 311 (2006) 656-659
12. Iwamoto J., et al. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin. Dig. Dis. Sci. 48 (2003) 2247-2256
13. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292 (1999) 195-202
14. Kliem H., et al. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum. Reproduction 134 (2007) 535-547
15. Kozak M. Mechanism of mRNA recognition by eukaryotic ribosomes during initiation of protein synthesis. Curr. Top. Microbiol. Immunol. 93 (1981) 81-123
16. Kratzschmar J., Haendler B., Kojima S., Rifkin D.B., and Schleuning W.D. Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene 125 (1993) 177-183
17. Kwak S.H., et al. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J. Leukocyte Biol. 78 (2005) 937-945
18. Lund L.R., et al. Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127 (2000) 4481-4492
19. Moller L.B., Ploug M., and Blasi F. Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur. J. Biochem. 208 (1992) 493-500
20. O'Mullane M.J., and Baker M.S. Elevated plasminogen receptor expression occurs as a degradative phase event in cellular apoptosis. Immunol. Cell Biol. 77 (1999) 249-255
21. Ohba K., Miyata Y., Kanda S., Koga S., Hayashi T., and Kanetake H. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. J. Urol. 174 (2005) 461-465
22. Ploug M., Kjalke M., Ronne E., Weidle U., Hoyer-Hansen G., and Dano K. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins. J. Biol. Chem. 268 (1993) 17539-17546
23. Ploug M., Ellis V., and Dano K. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry (Mosc). 33 (1994) 8991-8997
24. Politis I. Plasminogen activator system: implications for mammary cell growth and involution. J. Dairy Sci. 79 (1996) 1097-1107
25. Politis I., and Fragou S. Vitamin E and its effects on macrophages and neutrophils. In: Preedy V.R., and Watson R. (Eds). The Encyclopedia of Vitamin E (2006), CABI Publishing, Oxfordshire, UK 819-825
26. Politis I., Zavizjon B., Cheli F., and Baldi A. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils. J. Dairy Res. 69 (2002) 195-204
27. Quax P.H., et al. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 693-701
28. Rabot A., Sinowatz F., Berisha B., Meyer H.H., and Schams D. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution. J. Dairy Sci. 90 (2007) 740-748
29. Reuning U., Little S.P., Dixon E.P., Johnstone E.M., and Bang N.U. Molecular cloning of cDNA for the bovine urokinase-type plasminogen activator receptor. Thromb. Res. 72 (1993) 59-70
30. Tarui T., et al. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Thromb. Haemost. 95 (2006) 524-534
31. Wozniak S.E., Gee L.L., Wachtel M.S., and Frezza E.E. Adipose tissue: the new endocrine organ?. A Review Article. Dig. Dis. Sci. (2008) Electronic publication